C48H74O14
875.1 g/mol
APIDanger
Ivermectin B1a
CAS70161-11-4EC276-046-2
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material
Ivermectin B1a is a complex macrocyclic lactone compound that serves as an active pharmaceutical ingredient. It features a highly oxygenated, polycyclic structure with multiple ether linkages and alcohol groups, characteristic of the avermectin family.
Pharmaceutical raw material for manufacturingResearch compound for structural studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 70161-11-4
Related Compounds
StrongStructure SimilarSimilarity 0.86
Avermectin B2a
CAS65195-57-5
Veterinary antiparasitic agent
SimilarStructure SimilarSimilarity 0.84
3,4-Dihydro Ivermectin
CAS74567-01-4
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.79
Avermectin B2b
CAS65195-58-6
antiparasitic agent for agriculture
SimilarStructure SimilarSimilarity 0.79
Avermectin A2a
CAS65195-53-1
Veterinary antiparasitic agent
ReferenceSame Category
Cefaclor monohydrate
CAS70356-03-5
pharmaceutical raw material
ReferenceSame Category
Avobenzone
CAS70356-09-1
pharmaceutical raw material
ReferenceSame Category
Brimonidine D-tartrate
CAS70359-46-5
pharmaceutical raw material
ReferenceSame Category
Lornoxicam
CAS70374-39-9
pharmaceutical raw material
Safety Reference
Danger
H300Fatal if swallowed
H312Harmful in contact with skin
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
Identifiers
IUPAC Name
(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
InChIKey
AZSNMRSAGSSBNP-XPNPUAGNSA-N
SMILES
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C
Synonyms (39)
- IVM
- Ivermectin, British Pharmacopoeia (BP)
- Ivermectin, European Pharmacopoeia (EP)
- Ivermectin, United States Pharmacopeia (USP)
- 22,23-Dihydroavermectin B1a
- 71827-03-7 (Unlabelled)
- Dihydroavermectin B1a
- Eqvalan;
- H2B1a
- Hyvermectin;
- Ivermectin (IVM)
- Ivermectin (MK-0933)
- Ivermectin - Bio-X trade mark
- Ivermectin B1a
- Ivermectin B1a (>85%)
- Ivermectin B1a-d2
- Ivermectin Component B1a
- Ivermectin Impurity 39
- Ivomec;
- Mectizan;
- avermectin H2B1a
- dihydro avermectin Bla